|
Index of reports
> Cases resulting in death (5)
> Cases with Guillain-Barre Syndrome (3)
Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in death where reactions include guillain-barre syndrome.
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-02-20
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /; Diane
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-01-23
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Guillain-Barre Syndrome, Cytomegalovirus Infection, Muscle Spasms, Organ Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-01-16
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Death, Guillain-Barre Syndrome, Muscle Spasms
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /
|
